SpeeDx
As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.
SpeeDx Gets Regulatory Approval in Australia for COVID-19 Molecular Test Kit
The assay detects two regions of the SARS-CoV-2 virus that the firm claims are unaltered in all currently circulating variants.
SpeeDx, MolGen Partner for COVID-19 Testing
The agreement connects SpeeDx chemistry with MolGen's equipment for a fully integrated, high-throughput sample-to-answer workflow, the firms said.
CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC
SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well.
SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
Feb 11, 2020
SpeeDx Raises Additional $15M
Jan 13, 2020
SpeeDx, LabCorp Will Codevelop MDx Tests
Aug 5, 2019
SpeeDx Raises $15M in Equity Investment
Jun 24, 2019
SpeeDx, GSK Sign Test Supply, Development Deal
Jun 14, 2019
In Brief This Week: SpeeDx, Abbott
Apr 15, 2019
Mar 18, 2019
SpeeDx Signs Distributor Deals in Middle East
Jan 23, 2019
SpeeDx Signs Distribution Deals in Finland, Italy
Nov 8, 2018